← Leaderboards
Jonathan Chou
University Of California, San Francisco
$1,075,468
Attributed
$1,075,468
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $268.9K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,075,468 · 1
By mechanism
K08$1,075,468 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Paul L Nguyen$1,913,227
- Felix Yi-Chung Feng$6,764,664
- Scarlett L Gomez$14,448,454
- Lawrence Fong$19,816,074
- Leah S Karliner$4,161,856
Others in their field
Other Rising Stars on “Antagonist”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
Research focus
AntagonistChimeric Antigen Receptor T CellsAreaAwardAgonistBindingBinding SitesBiologicalBiopsy SpecimenBladder Transitional Cell CarcinomaAntibody-Drug ConjugatesCancer CellCancer CenterCancer Drug ResistanceCancer ModelCareer ChoiceCell LineCellsCell SurfaceCessation Of LifeCheckpoint TherapyChemotherapyCancer BiologyChromatin Immunoprecipitation
Grant awards (4)
Defining the roles of PPARgamma and TGFbeta in regulating NECTIN4 and resistance to NECTIN4-targeting therapies$268,867
K08 · FY2025 · CA · contact PI
Defining the roles of PPARgamma and TGFbeta in regulating NECTIN4 and resistance to NECTIN4-targeting therapies$268,867
K08 · FY2024 · CA · contact PI
Defining the roles of PPARgamma and TGFbeta in regulating NECTIN4 and resistance to NECTIN4-targeting therapies$268,867
K08 · FY2023 · CA · contact PI
Defining the roles of PPARgamma and TGFbeta in regulating NECTIN4 and resistance to NECTIN4-targeting therapies$268,867
K08 · FY2022 · CA · contact PI